AiDa Pharmaceuticals (AIDA) Stock Price & Analysis
AIDA Stock Chart & Stats
- Day’s Range
- $0.01 - $0.01
- 52-Week Range
- $0.01 - $0.01
- Previous Close
- $0.01
- Volume
- 500
- Average Volume (3M)
- 0
- Market Cap
- $8,127
- Enterprise Value
- N/A
- Total Cash (Recent Filing)
- N/A
- Total Debt (Recent Filing)
- $32.66M
- Price to Earnings (P/E)
- 0.0
- Beta
- 0.75
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
AIDA FAQ
What was AiDa Pharmaceuticals’s price range in the past 12 months?
What is AiDa Pharmaceuticals’s market cap?
When is AiDa Pharmaceuticals’s upcoming earnings report date?
Is AiDa Pharmaceuticals overvalued?
Does AiDa Pharmaceuticals pay dividends?
What is AiDa Pharmaceuticals’s EPS estimate?
How many shares outstanding does AiDa Pharmaceuticals have?
Which hedge fund is a major shareholder of AiDa Pharmaceuticals?
What is the TipRanks Smart Score and how is it calculated?
Company Description
AiDa Pharmaceuticals
Aida Pharmaceuticals, Inc., together with its affiliates, operates extensively throughout mainland China, specializing in the entire spectrum of pharmaceutical and genetic product development. This encompasses formulation, clinical trials, regulatory registration, manufacturing, sales, and marketing. The company's diverse product range includes antibiotics, cardiovascular medicines, and anti-cancer drugs. These are available in various forms, such as injectable powders, intravenous liquids, capsules, tablets, and ointments. Notable products feature Etimicin Sulfate, provided as an injectable powder, and rh-Apo2l, a biopharmaceutical therapy targeting cancers. Established in 1999, Aida Pharmaceuticals, Inc. is headquartered in Hangzhou, China.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Biao Jin
- Employees
- 450
- Website
- www.aidapharma.com
- Address
- 31 Dingjiang Road, Hangzhou, ZH, 310016, CN
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 3 | 3 | 8 |
| Technical Analysis | 1 | 1 | 0 |
| Moving Averages | 2 | 2 | 8 |